• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

PHO85 recombinant protein :: Cyclin-dependent protein kinase PHO85 (PHO85) Recombinant Protein

Scan QR to view Datasheet
Catalog # MBS1156779
Unit / Price
Scan QR to view Datasheet
  0.05 mg (E-Coli)  /  $710 +1 FREE 8GB USB
  0.05 mg (Yeast)  /  $820 +1 FREE 8GB USB
  0.2 mg (E-Coli)  /  $955 +1 FREE 8GB USB
  0.05 mg (Baculovirus)  /  $1,050 +1 FREE 8GB USB
  0.5 mg (E-Coli)  /  $1,050 +1 FREE 8GB USB
  0.2 mg (Yeast)  /  $1,105 +1 FREE 8GB USB
  0.5 mg (Yeast)  /  $1,255 +1 FREE 8GB USB
  0.05 mg (Mammalian-Cell)  /  $1,290 +1 FREE 8GB USB
  0.1 mg (Baculovirus)  /  $1,515 +1 FREE 8GB USB
  1 mg (E-Coli)  /  $1,585 +1 FREE 8GB USB
  0.5 mg (Baculovirus)  /  $1,975 +2 FREE 8GB USB
  1 mg (Yeast)  /  $1,990 +2 FREE 8GB USB
  0.1 mg (Mammalian-Cell)  /  $2,095 +2 FREE 8GB USB
  1 mg (Baculovirus)  /  $3,065 +3 FREE 8GB USB
PHO85 recombinant protein
Product Name

Cyclin-dependent protein kinase PHO85 (PHO85), Recombinant Protein

Full Product Name

Recombinant Saccharomyces cerevisiae Cyclin-dependent protein kinase PHO85 (PHO85)

Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Sequence Positions
1-305aa, full length protein
3D Structure
ModBase 3D Structure for P17157
E Coli or Yeast or Baculovirus or Mammalian Cell
>85% (SDS-PAGE) (lot specific)
Liquid containing glycerol
Tag Information
This protein contains an N-terminal tag and may also contain a C-terminal tag. Tag types are determined by various factors including tag-protein stability, please inquire for tag information.
Sterile filter available upon request.
Low endotoxin available upon request.
Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)
Storage Buffer
Tris-based buffer, 50% glycerol
Preparation and Storage
Store at -20 degrees C. For long-term storage, store at -20 degrees C or -80 degrees C. Store working aliquots at 4 degrees C for up to one week. Repeated freezing and thawing is not recommended.
ISO Certification
Manufactured in an ISO 13485:2003 and EN ISO 13485:2012 Certified Laboratory.
Other Notes
Small volumes of PHO85 recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
NCBI/Uniprot data below describe general gene information for PHO85. It may not necessarily be applicable to this product.
NCBI Accession #
NCBI GenBank Nucleotide #
UniProt Primary Accession #
UniProt Secondary Accession #
UniProt Related Accession #
Molecular Weight
34,906 Da
NCBI Official Full Name
cyclin-dependent serine/threonine-protein kinase PHO85
NCBI Official Symbol
PHO85  [Similar Products]
NCBI Official Synonym Symbols
  [Similar Products]
NCBI Protein Information
cyclin-dependent serine/threonine-protein kinase PHO85
UniProt Protein Name
Cyclin-dependent protein kinase PHO85
UniProt Synonym Protein Names
Negative regulator of the PHO system; Serine/threonine-protein kinase PHO85
UniProt Gene Name
PHO85  [Similar Products]
UniProt Synonym Gene Names
UniProt Comments for PHO85
Cyclin-dependent protein kinase (CDK) catalytic subunit that regulates multiple cell cycle and metabolic processes in response to nutrient availability. Associates with different cyclins, that control kinase activity, substrate specificity and subcellular location of the kinase. Favorable growth conditions always result in activated cyclin-CDK complexes. Regulates metabolic processes when associated with PHO80 cyclin family members (PH080, PCL6, PCL7, PCL8 and PCL10), and cell cycle and morphogenesis processes when associated with PCL1,2 cyclin family members (PCL1, PCL2, CLG1, PCL5 and PCL9). When associated with PHO80, negatively regulates the expression of phosphate-starvation-responsive genes under phosphate-rich conditions. The PHO80-PHO85 cyclin-CDK holoenzyme phosphorylates and inactivates the transcription factor PHO4 by promoting its export to the cytoplasm. PHO80-PHO85 phosphorylates and inactivates protein kinase RIM15 by retaining it in the cytoplasm, antagonizing RIM15-induced entry into stationary phase. PHO80-PHO85 also phosphorylates and inactivates the calcineurin-responsive transcription factor CRZ1, linking cyclin-CDK activity to calcium signaling. Together with the cyclins PCL6/PCL7 and PCL8/PCL10, negatively controls glycogen accumulation. When associated with cyclins PCL6 and PCL7, controls glycogen phosphorylase and glycogen synthase activities. PCL6-PHO85 and PCL7-PHO85 phosphorylate and inactivate the phosphatase PP1-2 inhibitor GLC8, causing activation of PP1-2, which then dephosphorylates and activates glycogen phosphorylase. When associated with cyclins PCL8 and PCL10, has glycogen synthase kinase activity. PCL10-PHO85 phosphorylates and negatively regulates glycogen synthase GSY2. Association with PCL1 and PCL2 is required for cell cycle progression at start in the absence of the CDC28-dependent G1 cyclins CLN1 and CLN2. PCL1-PHO85 is involved in phosphorylation of the CDK inhibitor (CKI) SIC1, which is required for its ubiquitination and degradation, releasing repression of b-type cyclins and promoting exit from mitosis. When associated with cyclins PCL1 and PCL2, positively controls degradation of sphingoid long chain base kinase LCB4 via phosphorylation of LCB4, which is required for its ubiquitination and degradation. PCL1-PHO85 also phosphorylates HMS1, NCP1 and NPA3, which may all have a role in mitotic exit. PCL2-PHO85 also phosphorylates RVS167, linking cyclin-CDK activity with organization of the actin cytoskeleton. When associated with PCL5, positively controls degradation of transcription factor GCN4 via phosphorylation of GCN4, which is required for its degradation by the E3 ubiquitin ligase complex SCF(Cdc4). When associated with PCL9, may have a role in bud site selection in G1 phase. PHO85 also phosphorylates the transcription factor SWI5.
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

Contact Us

Please fill out the form below and our representative will get back to you shortly.